TEWKSBURY, Mass.--(BUSINESS WIRE)--Cambridge Heart, Inc. (OTCBB:CAMH), today announced that it has reduced the size of its Board of Directors from seven members to five in order to reduce expenses and streamline the Company’s decision making process. As part of the reduction, Kenneth Hachikian, Reed Malleck and Dr. Richard Cohen resigned as directors of the Company effective December 30, 2009. Dr. Cohen will continue to work with the Company as a consultant and as Chairman of the Company’s Scientific Advisory Board, in which capacities he will interact with the Board of Directors on a regular basis. The Company also announced that Paul McCormick, former President and Chief Executive Officer of Endologix, Inc., has joined the Board of Directors effective December 30, 2009. Cambridge Heart now has three independent directors and two non-independent directors.
